- MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer (vol 308, e222830, 2023)Shi, Zhenwei*; Huang, Xiaomei; Cheng, Ziliang; Xu, Zeyan; Lin, Huan; Liu, Chen; Chen, Xiaobo; Liu, Chunling; Liang, Changhong; Lu, Cheng; Cui, Yanfen; Han, Chu; Qu, Jinrong; Shen, Jun; Li, ZaiyiRADIOLOGY, 2023, 308(1): e239021.
- Longitudinal MRI-based fusion novel model to predict pathological complete response in breast cancer treated with neoadjuvant chemotherapy: A multicenter, retrospective studyWang, Kun; Huang, YuhongAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
- Magnetic resonance imaging tumor regression shrinkage patterns during neoadjuvant chemotherapy versus neoadjuvant immunochemotherapy in triple-negative breast cancer (NeoMDSS-TN-SP): A nonrandomized, prospective cohort study.Zhang, Liulu; Zou, Jiachen; Chen, Yuanqi; Yan, Xinjian; Wang, KunAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
期刊论文
RETRACTION: Diffusion-weighted MR imaging of locally advanced breast carcinoma: the optimal time window of predicting the early response to neoadjuvant chemotherapy (Retraction of Vol 18, art no 38, 2018)
16阅读
